1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Triclabendazole Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Triclabendazole Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Prevalence rate of Fasciola hepatica in animal health
5.2. Sales Volume of Triclabendazole (Best effort Basis)
5.3. Pricing Analysis
5.4. Regulatory Scenario by Region/globally
5.5. COVID-19 Impact Analysis
6. Global Triclabendazole Market Analysis and Forecast, by Dosage Form
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Triclabendazole Market Value Forecast, by Dosage Form, 2017–2031
6.2.1. Tablet
6.2.2. Oral Suspension
6.3. Global Triclabendazole Market Attractiveness, by Dosage Form
7. Global Triclabendazole Market Analysis and Forecast, by Animal Type
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Triclabendazole Market Value Forecast, by Animal Type, 2017–2031
7.2.1. Cattle
7.2.2. Sheep
7.2.3. Goat
7.2.4. Others
7.3. Global Triclabendazole Market Attractiveness, by Animal Type
8. Global Triclabendazole Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Triclabendazole Market Value Forecast, by Distribution Channel, 2017–2031
8.2.1. Veterinary Hospitals
8.2.2. Veterinary Clinics
8.2.3. Pharmacies & Drug Stores
8.2.4. Others
8.3. Global Triclabendazole Market Attractiveness, by Distribution Channel
9. Global Triclabendazole Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Triclabendazole Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. North America Triclabendazole Market Attractiveness, by Region
10. North America Triclabendazole Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
10.2.1. Tablet
10.2.2. Oral Suspension
10.3. North America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
10.3.1. Cattle
10.3.2. Sheep
10.3.3. Goat
10.3.4. Others
10.4. North America Triclabendazole Market Value Forecast, by Distribution Channel, 2017–2031
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.4.3. Pharmacies & Drug Stores
10.4.4. Others
10.4.5. North America Triclabendazole Market Attractiveness, by Distribution Channel
10.5. North America Triclabendazole Market Value (US$ Mn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America Triclabendazole Market Attractiveness Analysis
10.6.1. By Dosage Form
10.6.2. By Animal Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Triclabendazole Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
11.2.1. Tablet
11.2.2. Oral Suspension
11.3. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
11.3.1. Cattle
11.3.2. Sheep
11.3.3. Goat
11.3.4. Others
11.4. Europe Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Rest of Europe
11.5. Europe Triclabendazole Market Attractiveness Analysis
11.5.1. By Dosage Form
11.5.2. By Animal Type
11.5.3. By Distribution Channel
11.5.4. By Country/Sub-region
12. Asia Pacific Triclabendazole Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
12.2.1. Tablet
12.2.2. Oral Suspension
12.3. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
12.3.1. Cattle
12.3.2. Sheep
12.3.3. Goat
12.3.4. Others
12.4. Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Triclabendazole Market Attractiveness Analysis
12.5.1. By Dosage Form
12.5.2. By Animal Type
12.5.3. By Distribution Channel
12.5.4. By Country/Sub-region
13. Latin America Triclabendazole Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
13.2.1. Tablet
13.2.2. Oral Suspension
13.3. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
13.3.1. Cattle
13.3.2. Sheep
13.3.3. Goat
13.3.4. Others
13.4. Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America Latin America
13.5. Latin America Triclabendazole Market Attractiveness Analysis
13.5.1. By Dosage Form
13.5.2. By Animal Type
13.5.3. By Distribution Channel
13.5.4. By Country/Sub-region
14. Middle East & Africa Triclabendazole Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
14.2.1. Tablet
14.2.2. Oral Suspension
14.3. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
14.3.1. Cattle
14.3.2. Sheep
14.3.3. Goat
14.3.4. Others
14.4. Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of Middle East & Africa
14.5. Middle East & Africa Triclabendazole Market Attractiveness Analysis
14.5.1. By Dosage Form
14.5.2. By Animal Type
14.5.3. By Distribution Channel
14.5.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share / Position Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. AdvaCare Pharma
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Financial Analysis
15.4.1.3. Growth Strategies
15.4.1.4. SWOT Analysis
15.4.2. RV Lifesciences Limited
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Financial Analysis
15.4.2.3. Growth Strategies
15.4.2.4. SWOT Analysis
15.4.3. Grampus Laboratories
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Financial Analysis
15.4.3.3. Growth Strategies
15.4.3.4. SWOT Analysis
15.4.4. Intas Pharmaceuticals Ltd
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Financial Analysis
15.4.4.3. Growth Strategies
15.4.4.4. SWOT Analysis
15.4.5. Shanghai Tongren Pharmaceutical Co., Ltd.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Financial Analysis
15.4.5.3. Growth Strategies
15.4.5.4. SWOT Analysis
15.4.6. Shijiazhuang Shimu Animal Pharmaceutical Co., Ltd.
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Financial Analysis
15.4.6.3. Growth Strategies
15.4.6.4. SWOT Analysis
15.4.7. Siflon Drugs & Pharmaceuticals Pvt. Ltd.
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Financial Analysis
15.4.7.3. Growth Strategies
15.4.7.4. SWOT Analysis
15.4.8. Elanco
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Financial Analysis
15.4.8.3. Growth Strategies
15.4.8.4. SWOT Analysis
15.4.9. Virbac
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Financial Analysis
15.4.9.3. Growth Strategies
15.4.9.4. SWOT Analysis
15.4.10. Bimeda, Inc.
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Financial Analysis
15.4.10.3. Growth Strategies
15.4.10.4. SWOT Analysis
15.4.11. Chanelle Pharma
15.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.11.2. Financial Analysis
15.4.11.3. Growth Strategies
15.4.11.4. SWOT Analysis
15.4.12. Zoetis Health
15.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.12.2. Financial Analysis
15.4.12.3. Growth Strategies
15.4.12.4. SWOT Analysis
List of TablesTable 01: Global Triclabendazole Market Volume (000 Unit) Forecast, by Oral Suspension, 2017–2031
Table 02: Global Triclabendazole Market Volume (000 Unit) Forecast, by Tablet, 2017–2031
Table 03: Global Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 04: Global Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 05: Global Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 06: Global Triclabendazole Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 07: North America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 08: North America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 09: North America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 10: North America Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 11: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 13: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 14: Europe Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 15: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 17: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 18: Asia Pacific Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 19: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 20: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 21: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 22: Latin America Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
Table 23: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 24: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Dosage Form, 2017–2031
Table 25: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Animal Type, 2017–2031
Table 26: Middle East & Africa Triclabendazole Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer